- HOME
- News
Announcement on the Submission of the Application of Manufacturing and Marketing Authorization for Allogeneic iPS Cell-Derived dopaminergic neural progenitor cells in Japan
Research and Development
2025.12.24
Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; “Sumitomo Pharma”) and RACTHERACo., Ltd. (Head Office: C…
RACTHERA Inc. Corporate Website Launch Announcement
Company
2025.12.24
RACTHERA Inc. has launched its corporate website. We are a joint venture established through joint investment …